PT  - JOURNAL ARTICLE
AU  - Zhu, Haoming
AU  - Yang, Xiaotong
AU  - Xie, Wanling
AU  - Langen, Elizabeth
AU  - Li, Ruowang
AU  - Gamire, Lana X
TI  - Discover overlooked complications after preeclampsia using electronic health records
AID  - 10.1101/2023.12.05.23299296
DP  - 2024 Jan 01
TA  - medRxiv
PG  - 2023.12.05.23299296
4099  - http://medrxiv.org/content/early/2024/02/15/2023.12.05.23299296.short
4100  - http://medrxiv.org/content/early/2024/02/15/2023.12.05.23299296.full
AB  - Background Preeclampsia (PE) is a severe pregnancy complication characterized by hypertension and end-organ damage such as proteinuria. PE poses a significant threat to women’s long-term health, including an increased risk of cardiovascular and renal diseases. Most previous studies have been hypothesis-based, potentially overlooking certain significant complications. This study conducts a comprehensive, non-hypothesis-based analysis of PE-complicated diagnoses after pregnancies using multiple large-scale electronic health records (EHR) datasets.Method From the University of Michigan (UM) Healthcare System, we collected 4,348 PE patients for the cases and 27,377 patients with pregnancies not complicated by PE or related conditions for the controls. We first conducted a non-hypothesis-based analysis to identify any long-term adverse health conditions associated with PE using logistic regression with adjustments to demographics, social history, and medical history. We confirmed the identified complications with UK Biobank data which contain 443 PE cases and 14,870 non-PE controls. We then conducted a survival analysis on complications that exhibited significance in more than 5 consecutive years post-PE. We further examined the potential racial disparities of identified complications between Caucasian and African American patients.Findings Uncomplicated hypertension, complicated diabetes, congestive heart failure, renal failure, and obesity exhibited significantly increased risks whereas hypothyroidism showed decreased risks, in 5 consecutive years after PE in the UM discovery data. UK Biobank data confirmed the increased risks of uncomplicated hypertension, complicated diabetes, congestive heart failure, renal failure, and obesity. Further survival analysis using UM data indicated significantly increased risks in uncomplicated hypertension, complicated diabetes, congestive heart failure, renal failure, and obesity, and significantly decreased risks in hypothyroidism. There exist racial differences in the risks of developing hypertension and hypothyroidism after PE. PE protects against hypothyroidism in African American postpartum women but not Cacausians; it also increases the risks of uncomplicated hypertension but less severely in African American postpartum women as compared to Cacausians.Interpretation This study addresses the lack of a comprehensive examination of PE’s long-term effects utilizing large-scale EHR and advanced statistical methods. Our findings underscore the need for long-term monitoring and interventions for women with a history of PE, emphasizing the importance of personalized postpartum care. Notably, the racial disparities observed in the impact of PE on hypertension and hypothyroidism highlight the necessity of tailored aftercare based on race.Competing Interest StatementLXG is a member of the Scientific Advisory Boards of Simulations Plus.Funding StatementXY is supported by T32GM141746 fellowship. LXG is supported by grants by NIH/NIGMS, R01 LM012373 and R01 LM012907 awarded by NLM, and R01 HD084633 awarded by NICHD. WX and RL are supported by the Neurology Collaborative Pilot Funding Awards awarded by Cedars-Sinai Medical Center.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics committee/IRB of the University of Michigan gave ethical approval for this workI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe EHR used in this study contains sensitive patient information and cannot be made public. Researchers meeting the criteria for using sensitive data may contact the Research Scientific Facilitators at the University of Michigan Precision Health by emailing PHDataHelp{at}umich.edu or visiting https://research.medicine.umich.edu/our-units/data-office-clinical-translational-research/data-access for more information about requesting data access.https://research.medicine.umich.edu/our-units/data-office-clinical-translational-research/data-access PEpreeclampsiaEHRelectronic health recordUMUniversity of MichiganIRBInstitutional Review BoardICDInternational Classification of DiseasesORodds ratioCIconfidence intervalVIFVariance Inflation FactorCox-PHCox Proportional-HazardHRHazard ratio